Mirum Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $670.8M
Liabilities Breakdown FY2024
Total Liabilities: $445.1M
Asset Breakdown
Total Assets: $670.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $222.5M | 33.2% |
| Accounts Receivable | $78.3M | 11.7% |
| Inventory | $22.4M | 3.3% |
| Property, Plant & Equipment | $1.1M | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $249.8M | 37.2% |
| Other Assets | $96.6M | 14.4% |
Liabilities Breakdown
Total Liabilities: $445.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $14.6M | 3.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $430.5M | 96.7% |